Samsung Pharmaceutical Co Ltd
001360
Company Profile
Business description
Samsung Pharmaceutical Co Ltd is a South Korea-based company engaged in pharmaceutical manufacturing and sales, bio business, and health food sales. The company's products are Prescription drugs, General medicine, Non-medicinal products, Health functional food, and others.
Contact
10, Yakjakgongdan 4-gil
Hyangnam-eup
Gyeonggi-do
Hwaseong-si
KORT: +82 313536681
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
88
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,024.20 | 27.20 | -0.30% |
| CAC 40 | 8,163.02 | 6.59 | 0.08% |
| DAX 40 | 24,070.83 | 124.07 | -0.51% |
| Dow JONES (US) | 49,490.03 | 340.65 | 0.69% |
| FTSE 100 | 10,387.81 | 88.65 | -0.85% |
| HKSE | 25,915.20 | 248.04 | -0.95% |
| NASDAQ | 24,657.57 | 397.60 | 1.64% |
| Nikkei 225 | 59,140.23 | 445.63 | -0.75% |
| NZX 50 Index | 12,884.93 | 60.67 | -0.47% |
| S&P 500 | 7,137.90 | 73.89 | 1.05% |
| S&P/ASX 200 | 8,793.40 | 26.10 | -0.30% |
| SSE Composite Index | 4,093.25 | 13.01 | -0.32% |